This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy
for refractory brain metastases.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03027544
Ages eligible for Study
18 Years to 75 Years
Genders eligible for Study
Accepts Healthy Volunteers
Histologic or cytologic diagnosis of primary tumor and conformed brain metastases by enhanced MRI or CT; the lesion number is no less than 3; or the tumor volume is no smaller than 6cc; or tumor diameter is no shorter than 3cm; or uncontrolled brain tumor after whole brain radiotherapy(WBRT); or the tumor is adjacent to essential structures of the brain, such as brain stem, optic chiasma, optic tract, etc; KPS
≥60,or KPS ≥40 and the limitation of motion is simply caused by brain tumor that is adjacent to the motor function areas; Age: 18-75 years old; Adequate end-organ function: WBC≥4.0x109/L Neu ≥ 1.5x109/L Hemoglobin ≥ 110 g/L Platelets ≥100 x109/L Total bilirubin ≤ 1.5x ULN AST and ALT ≤ 1.5x ULN BUN and Cr: within the normal range.
• Other clinically significant diseases (e.g.myocardial infarction within the past 6 months, severe arrhythmia).
Unable or unwilling to comply with the study protocol.
The expected survival time is less than 3 months.
Patients who are anticipated in other clinical trials of brain metastases.
Patients who has been treated with SRT in other hospitals
Pregnant patients or female patients whose HCG is positive
Unsuitable to participate in study, that in the opinion of the treating physician.
All locations for NCT03027544
Chinese Academy of Medical Sciences
Beijing, Beijing, China, 100021
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT03027544. The sponsor of the trial is Chinese Academy of Medical Sciences and it is looking for 150 volunteers for the current phase.
Official trial title: Tomotherapy for Refractory Brain Metastases: a Single Arm, Single Center Phase II Trial
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.